Andere Sprachen Adocia

Aktien

A1JTC2

FR0011184241

ADOC

Markt geschlossen - Euronext Paris Andere Börsenplätze 17:35:22 31.05.2024			% 5 Tage	% 1. Jan.
9 ^EUR	+3.57%		-0.66%	-22.01%

24.04.	Adocia SA meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
24.04.	Adocia SA meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2023	24.04.
Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2023	24.04.
Adocia Reveals Promising Preclinical Data on Adocia Islets for Cell Therapy of Diabetes	09.11.
Adocia SA Reports Earnings Results for the Half Year Ended June 30, 2023	18.09.23
Adocia Signs an Exclusivity Agreement with Sanofi for M1Pram	05.07.23
Adocia SA Auditor Raises 'Going Concern' Doubt	28.04.23
Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2022	15.03.23
Adocia Jumps 11% as BioChaperone Lispro Shows Faster Absorption in Early-stage Insulin Injection Trial	29.12.22
Adocia SA Announces the Successful Phase 1 Study for Biochaperone® Lispro with Partner Tonghua Dongbao	29.12.22
Adocia's Phase 2 Study of M1Pram Shows Better Weight Loss, Appetite Control in Diabetic Obese People; Shares Surge 13%	06.10.22
Adocia Sa Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes Using M1pram in A Post-Hoc Analysis	06.10.22
Adocia SA Reports Earnings Results for the Half Year Ended June 30, 2022	19.09.22
Adocia Obtains Preclinical Proof of Concept for Investigational Diabetes Therapy; Shares Up 9%	07.09.22
ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell(R) Islets for the Treatment of Type 1 Diabetes	07.09.22
Adocia Treats First Patient in Clinical Trial for Insulin Combo	18.05.22
ADOCIA Announces First Subject Treated In BioChaperone® Combo Clinical Studies with Partner Tonghua Dongbao	18.05.22
Adocia's Chinese Partner Treats First Patient In Late-stage Study Of Diabetes Drug	09.05.22
Adocia Announces the First Patient Dosed in the BioChaperone® Lispro Phase 3 Program with Partner Tonghua Dongbao	09.05.22
Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2021	19.04.22
Adocia Receives German Approval To Start Three Trials On Insulin Combo	11.04.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Adocia

Aktien

A1JTC2

FR0011184241

ADOC

Andere Sprachen

Filter